🟢 Connect Biopharma is trading 7.22% up in pre-market with no catalyst identified

Connect Biopharma is trading 7.22% up at $2.19, with no new company-specific catalyst identified for September 14, 2026.

• Management’s September 15 H.C. Wainwright presentation remains the main upcoming item; topline Phase 2 Seabreeze STAT data are expected during September.
• The broader market is weaker pre-market, so the gain does not clearly track index sentiment; speculative interest may be contributing, but the immediate reason remains unconfirmed.